Bryan Walker
Psychiatric/Mental Health · Round Rock, TXNPI 1497325690
Payments from drug & device makers
Across 159 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$667
- Axsome Therapeutics, Inc.$463
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$341
- Supernus Pharmaceuticals, Inc.$241
- Johnson & Johnson$225
- Takeda Pharmaceuticals U.S.A., Inc.$204
- plus $862 from 10 others
What the payments were for
- Consulting fees$1154%
- Food & beverage$2,88096%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 45 | $667 |
| Axsome Therapeutics, Inc. | 21 | $463 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $341 |
| Supernus Pharmaceuticals, Inc. | 16 | $241 |
| Johnson & Johnson | 11 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $204 |
| AbbVie | 10 | $175 |
| Alkermes, Inc. | 3 | $165 |
| Neurocrine Biosciences, Inc. | 6 | $151 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| Ironshore Pharmaceuticals Inc. | 4 | $78 |
| Biogen | 1 | $31 |
| Bioxcel Therapeutics, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,002 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 16 | $1,504 |
| Duloxetine Hcl | 41 | $595 |
| Hydroxyzine Hcl | 16 | $204 |
| Quetiapine Fumarate | 18 | $199 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $146 |
| Gabapentin | 14 | $125 |
| Bupropion XlBupropion Hcl | 23 | $124 |
| Clonazepam | 28 | $113 |
| Oxcarbazepine | 22 | $113 |
| Sertraline Hcl | 19 | $104 |
| Alprazolam | 20 | $67 |
| Trazodone Hcl | 23 | $44 |
| Lorazepam | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Round Rock
- Komi Kokou-AbiRound Rock$88K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.